12H·

Valuation Healthcare sector - Goldman Sachs

9
5 Comentários

imagem de perfil
I still have one US pharma share on my buy list.
But I'm wondering whether I should get in before August.
1
imagem de perfil
@Tenbagger2024 I don't think anyone can answer that 😁. I think the healthcare sector for diversification is certainly not a mistake at the moment.
1
imagem de perfil
@Tenbagger2024 would expect a rotation from August. Tariffs on everything will be higher than expected, pharma will remain exempt as Trump cannot afford this. The requirement to produce in the USA in 1-2 years is still a long way off (current requirement) and many are already producing there (not counting preliminary products).
1
imagem de perfil
If you define yourself as a long-term investor, you can definitely bag favorable entry prices here! The revaluation will come, especially when momentum is lower. So far I have bought $TMO $MRK $AZN. I think we will see more inflows here again from August.
1
imagem de perfil
@Michey777 I see it the same way 👌
1
Participar na conversa